Submerged culture mycelium and broth of grifola frondosa improve glycemic responses in diabetic rats

American Journal of Chinese Medicine

Volumn 36, Issue 2, 2008, Pages 265-285

  Lo, Hui Chen ^a,b   Hsu, Tai Hao ^c   Chen, Ching Yi ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c DA YEH UNIVERSITY   (Taiwan)

Author keywords

Diabetes Mellitus; Fructosamin; Grifola frondosa; OGTT; Postprandial Blood Glucose

Indexed keywords

FRUCTOSAMINE; GLUCOSE; GRIFOLA FRONDOSA EXTRACT; NATURAL PRODUCT; NICOTINAMIDE; PLACEBO; SODIUM CHLORIDE; STREPTOZOCIN; TRIACYLGLYCEROL;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROTH DILUTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG MECHANISM; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRIFOLA; GRIFOLA FRONDOSA; MALE; MYCELIUM; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; RAT; STREPTOZOCIN DIABETES; SUBMERGED FERMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FERMENTATION; GLUCOSE TOLERANCE TEST; GRIFOLA; MALE; MYCELIUM; NIACINAMIDE; PHYTOTHERAPY; PLANT EXTRACTS; POSTPRANDIAL PERIOD; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 44049106412     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X0800576X     Document Type: Article

References (40)

1. Adachi, K., H. Nanba and H. Kuroda. Potentiation of host-mediated antitumor activity in mice by β-glucan obtained from Grifola frondosa (maitake). Chem. Pharm. Bull. 35: 262-270, 1987.
2. Adachi, Y., N. Ohno and T. Yadomae. Activation of murine kupffer cells by administration with gel-forming (1 ←3)-β-D-glucan from Grifola frondosa. Biol. Pharm. Bull. 21: 278-283, 1998.
3. AOAC. Official Methods of Analysis, 16th ed. Association of Official Analytical Chemists, Arlington, VA, 1995.
4. Bae, J.T., G.S. Sim, D.H. Lee, B.C. Lee, H.B. Pyo, T.B. Choe and J.W. Yun. Production of exopolysaccharide from mycelial culture of Grifola frondosa and its inhibitory effect on matrix metalloproteinase-1 expression in UV-irradiated human dermal fibroblasts. FEMS Microbiol. Lett. 251: 347-354, 2005.
5. Bonora, E. and M. Muggeo. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: The epidemiological evidence. Diabetologia 44: 2107-2114, 2001.
6. Crisan, E.V. and A. Sands. Nutrition value. In: S.T. Chang and W.A. Hayes (eds.) The Biology and Cultivation of Edible Mushrooms. Academic Press, New York, 1978, pp. 137-165.
7. Dubois, M., K.A. Gilles, J.K. Hamilton, P.A. Rebers and F. Smith. Colorimetric methods for determination of sugars and related substances. Anal. Chem. 28: 350-356, 1956.
8. FDA. Guidance for Industry and Reviewers: Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers, 2002, p. 7.
9. Fukushima, M., T. Ohashi, Y. Fujiwara, K. Sonoyama and M. Nakano. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp. Biol. Med. 226: 758-765, 2001.
10. Hogan, P., T., Dall and P. Nikolov. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26: 917-932, 2003.
11. Horio, H. and M. Ohtsuru. Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. J. Nutr. Sci. Vitaminol. 47: 57-63, 2001.
12. Hsieh, C., C.J. Liu, M.H. Tseng, C.T. Lo and Y.C. Yang. Effect of olive oil on the production of mycelial biomass and polysaccharides of Grifola frondosa under-high oxygen concentration aeration. Enzyme Microb. Technol. 39: 434-439, 2006.
13. Inoue, A., N. Kodama and H. Nanba. Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol. Pharm. Bull. 25: 536-540, 2002.
14. Ishibashi, K., N.N. Miura, Y. Adachi, N. Ohno and T. Yadomae. Relationship between solubility of grifolan, a fungal 1,3-Wb-D-glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci. Biotechnol. Biochem. 65: 1993-2000, 2001.
15. Johnson, R.N., P.A. Metcalf and J.R. Baker. Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 127: 87-95, 1983.
16. Kabir, Y. and S. Kimura. Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). J. Nutr Sci. Vitaminol. 35: 91-94, 1989.
17. Kodama, N., M. Yamada and H. Nanba. Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn. J. Pharmacol. 87: 327-332, 2001.
18. Kodama, N., K. Komuta, N. Sakai and H. Nanba. Effects of D-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol. Pharm. Bull. 25: 1647-1650, 2002.
19. Kodama, N., K. Komuta and H. Nanba. Effect of Maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J. Med. Food 6: 371-317, 2003.
20. Kodama, N., Y. Murata and H. Nanba. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. J. Med. Food 7: 141-145, 2004.
21. Kodama, N., Y. Murata, A. Asakawa, A. Inui, M. Hayashi, N. Sakai and H. Nanba. Maitake D-fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition 21: 624-629, 2005.
22. Kubo, K., H. Aoki and H. Nanba. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). Biol. Pharm. Bull. 17: 1106-1110, 1994.
23. Kubo, K. and H. Nanba. Anti-hyperliposis effect of maitake fruit body (Grifola frondosa). Biol. Pharm. Bull. 20: 781-785, 1997.
24. Lee, B.C., J.T Bae, H.B. Pyo, T.B. Choe, S.W. Kim, H.J. Hwang and J.W. Yuri. Submerged culture conditions for the production of mycelial biomass and exopolysaccharides by the edible Basidiomycete Grifola frondosa. Enzyme Microb. Technol. 35: 369-376, 2004.
25. Lin, H., Y.H. She, B.R. Cassileth, F. Sirotnak and R.S. Cunningham. Maitake β-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Intl. Immunopharmacol. 4: 91-99, 2004.
26. Lo, H.C., S.T. Tu, K.C. Lin and S.C. Lin. The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide aud streptozotocin. Life Sci. 74: 2897-2908, 2004.
27. Lo, H.C., F.A. Tsai, S.P. Wasser, J.G. Yang and B.M. Huang. Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:FR. on glycemic responses in normal and diabetic rats. Life Sci. 78: 1957-1966, 2006.
28. Manohar, V., N.A. Talpur, B.W. Echard, S. Lieberman and H.G. Pretiss. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes. Metab. 4: 43-48, 2002.
29. Masiello, P., C. Broca, R. Gross, M. Roye, M. Manteghetti, D. Hillaire-Buys, M. Novelli and G. Ribes. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229, 1998.
30. Mayell, M. Maitake extracts and their therapeutic potential. Altern. Med. Rev. 6: 48-60, 2001.
31. Nakai, R., H. Masui, H. Horio and M. Ohtsuru. Effect of maitake ( Grifola frondosa) water extract on inhibition of adipocyte conversion of C3H10T1/2B2C1 cells. J. Nutr. Sci. Vitaminol. 45: 385-389, 1999.
32. Nanba, H., A. Hamaguchi and H. Kuroda. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chein. Pharm. Bull. 35: 1162-1168, 1987.
33. Ohno, N., Y. Adachi, I. Suzuki, S. Oikawa, K. Sato, M. Ohsawa and T. Yadomae. Antitumor activity of a β-1,3-glucan obtained from liquid cultured mycelium of Grifola frondosa. J. Pharmacobiodyn. 9: 861-864, 1986.
34. Okazaki, M., Y. Adachi, N. Ohno and T. Yadomae. Structure-activity relationship of (1←3)-β-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol..Pharm. Bull. 18: 1320-1327, 1995.
35. Sanzen, I., N. Imanishi, N. Takamatsu, S. Konosu, N. Mantani, K. Terasawa, K. Tazawa, Y. Odaira, M. Watanabe, M. Takeyama and H. Ochiai. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (Maitake mushroom) in a macrophage cell line, RAW264.7. J. Exp. Clin. Cancer Res. 20: 591-597, 2001.
36. Talpur, N., B. Echard, A. Dadgar, S. Aggarwal, C. Zhuang, D. Bagchi and H.G. Preuss. Effects of Maitake mushroom frations on blood pressure of Zucker fatty rats. Res. Commun. Mol. Pathol. Pharmacol. 112: 68-82, 2002.
37. Talpur, N., B.W. Echard, T. Yasmin, D. Bagchi and H.G. Preuss. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol. Cell Biochem. 252: 369-377, 2003.
38. Winer, N. and J.R. Sowers. Epidemiology of diabetes. J. Clin. Pharmacol. 44: 397-405, 2004,
39. Wu, M.J., T.L. Cheng, S.Y. Cheng, T.W. Lian, L. Wang and S.Y. Chiou. Immunomodulatory properties of Grifola frondosa in submerged culture. J. Agric. Food Chem. 54: 2906-2914, 2006.
40. Zhang, Y., G.L. Mills and M.G. Nair. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J. Agric. Food Chem. 50: 7581-7585, 2002.